 |
|
|
[ send your article ] Articles 05More articles: [newest], [05], [04], [03], [02], [01] Over the past seven to eight years there has been noted a proliferation of minimally invasive surgery (MIS) techniques for the treatment of urologic malignancies. This evolution is no better demonstrated than the radical prostatectomy procedure for patients with prostate cancer. [ read full article ] According to a recent study sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought. [ read full article ] After a comprehensive appraisal of the management and treatment options for low-risk prostate cancer, a recent report prepared the by Institute for Clinical and Economic Review (ICER), found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably. [ read full article ] Today, urologists agree that is not yet well-defined who is really a candidate for active surveillance (watchful waiting) as opposed to early treatment for prostate cancer that is supposedly localized. [ read full article ] Men diagnosed with low-risk localised prostate cancer often face the difficulty of choosing an appropriate treatment. Localised prostate cancer can be treated curatively or managed expectantly with active surveillance (AS). [ read full article ] Statistics show that minimally invasive radical prostatectomy (MIRP) for prostate cancer (CaP) is the most common treatment modality for localized CaP in the United States. The popularity of this treatment in part is due to marketing and patient driven desire for the procedure. [ read full article ] Statistics show that more than one-third of the estimated 2 million prostate cancer survivors in the United States receive androgen deprivation therapy (ADT). [ read full article ] Research and Markets has announced the addition of the "Prostate Cancer Therapeutics - A Global Market Perspective" report to their offering. [ read full article ] Prostate cancer is the most frequent malignancy in men and predominantly in elderly men. The issue of prostate cancer is likely to assume greater importance with progressive aging of the population. With frequent use of PSA testing most patients were diagnosed with localized cancer even in senior adults. [ read full article ] Reportlinker.com announces that a new market research report is available in its catalogue: Prostate Cancer Therapeutics - A Global Market Perspective. [ read full article ] This study found that the majority of men with early prostate cancer (PC) included in a protocol-based program for active surveillance (AS) show favorable anxiety and distress scores when compared to reference values and to groups of patients with PC who underwent other treatments. [ read full article ] A dissertation thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden, shows that men who have prostate cancer often feel quite healthy, but the diagnosis still gives them a whole new outlook on life. Once they have learned to live with their cancer, they choose to focus on valuable relationships and appreciate the little things in life. [ read full article ] The global leader in the field of radiosurgery, Accuray Incorporated (Nasdaq: ARAY), announced today publication of results from a study of early stage prostate cancer patients treated with CyberKnife Radiosurgery. [ read full article ] A new study in the Journal of the American Medical Association (JAMA) appears to support the theory outlined in earlier studies that men with more advanced forms of prostate cancer don't benefit from a combination of hormone and radiation therapy. [ read full article ] A new study at the Dartmouth Medical School's Institute for Health Policy and Clinical Practice concludes mass screening for prostate cancer with a test for prostate-specific antigen (PSA) has led to mass over-diagnosis and over-treatment [ read full article ] The digital rectal exam ( DRE, shortly) is considered as an essential part of the early detection and diagnosis of prostate cancer. However, because any examined man expects important info related to his health, DRE is also a source of anxiety. [ read full article ] If you are a male, especially an African American male that is way above 40 years of age, you should be very concerned about prostate cancer. Many people continue to ask - what does prostate type of cancer have to do with genetics? Others continue to ask - Is Prostate Cancer genetic or not. [ read full article ] For many prostate cancer patients making the decision about which treatment option to choose may feel overwhelming. The good thing is that prostate cancer is slow growing, so this gives you time to research and carefully consider all of your choices. [ read full article ] According to the National Cancer Institute, nearly 16 percent of men born today will be diagnosed with cancer of the prostate at some time during their lifetime and the biggest risk factor for this type of cancer is age. [ read full article ] It is well known that a diet of vegetables, fruits, nuts, olive oil and pulses, washed down with a glass of red wine, helps boost longevity. Specialists call this the traditional Mediterranean diet and claim that it may also help decrease the risk of prostate problems in men. [ read full article ] More articles: [newest], [05], [04], [03], [02], [01] [ send your article ] NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|